Aletaha Daniel, Neogi Tuhina, Silman Alan J, Funovits Julia, Felson David T, Bingham Clifton O, Birnbaum Neal S, Burmester Gerd R, Bykerk Vivian P, Cohen Marc D, Combe Bernard, Costenbader Karen H, Dougados Maxime, Emery Paul, Ferraccioli Gianfranco, Hazes Johanna M W, Hobbs Kathryn, Huizinga Tom W J, Kavanaugh Arthur, Kay Jonathan, Kvien Tore K, Laing Timothy, Mease Philip, Ménard Henri A, Moreland Larry W, Naden Raymond L, Pincus Theodore, Smolen Josef S, Stanislawska-Biernat Ewa, Symmons Deborah, Tak Paul P, Upchurch Katherine S, Vencovský Jirí, Wolfe Frederick, Hawker Gillian
Medical University of Vienna, Vienna, Austria.
Arthritis Rheum. 2010 Sep;62(9):2569-81. doi: 10.1002/art.27584.
The 1987 American College of Rheumatology (ACR; formerly, the American Rheumatism Association) classification criteria for rheumatoid arthritis (RA) have been criticized for their lack of sensitivity in early disease. This work was undertaken to develop new classification criteria for RA.
A joint working group from the ACR and the European League Against Rheumatism developed, in 3 phases, a new approach to classifying RA. The work focused on identifying, among patients newly presenting with undifferentiated inflammatory synovitis, factors that best discriminated between those who were and those who were not at high risk for persistent and/or erosive disease--this being the appropriate current paradigm underlying the disease construct "rheumatoid arthritis."
In the new criteria set, classification as "definite RA" is based on the confirmed presence of synovitis in at least 1 joint, absence of an alternative diagnosis that better explains the synovitis, and achievement of a total score of 6 or greater (of a possible 10) from the individual scores in 4 domains: number and site of involved joints (score range 0-5), serologic abnormality (score range 0-3), elevated acute-phase response (score range 0-1), and symptom duration (2 levels; range 0-1).
This new classification system redefines the current paradigm of RA by focusing on features at earlier stages of disease that are associated with persistent and/or erosive disease, rather than defining the disease by its late-stage features. This will refocus attention on the important need for earlier diagnosis and institution of effective disease-suppressing therapy to prevent or minimize the occurrence of the undesirable sequelae that currently comprise the paradigm underlying the disease construct "rheumatoid arthritis."
1987年美国风湿病学会(ACR;前身为美国风湿病协会)类风湿关节炎(RA)分类标准因对疾病早期缺乏敏感性而受到批评。开展这项工作是为了制定新的RA分类标准。
ACR和欧洲抗风湿病联盟联合工作组分3个阶段制定了一种新的RA分类方法。这项工作重点是在新出现未分化炎性滑膜炎的患者中,找出最能区分持续性和/或侵蚀性疾病高风险患者与非高风险患者的因素——这是当前“类风湿关节炎”疾病结构的适当范式。
在新的标准集中,“确诊RA”的分类基于至少1个关节滑膜炎的确诊、不存在能更好解释滑膜炎的其他诊断,以及在4个领域的单项得分总和达到6分或更高(满分10分):受累关节的数量和部位(得分范围0 - 5)、血清学异常(得分范围0 - 3)、急性期反应升高(得分范围0 - 1)和症状持续时间(2个级别;范围0 - 1)。
这种新的分类系统通过关注疾病早期与持续性和/或侵蚀性疾病相关的特征,而不是通过疾病晚期特征来定义疾病,重新定义了当前的RA范式。这将重新把注意力集中在早期诊断和实施有效的疾病抑制治疗的重要需求上,以预防或尽量减少目前构成“类风湿关节炎”疾病结构范式的不良后遗症的发生。